AKUOS
AKUOS is a product that helps augment human capabilities and allows people to overcome physical limitations caused by conditions such as hearing loss. Designers use technology to optimise everyday life and human experiences through excellent quality, stylish, and seamless product solutions that enable our customers to live their best lives through human-centric engineering and design processes. Using cutting-edge engineering, artificial intelligence, and manufacturing, designers create devices that enable people to be and do more, addressing not only disabilities but also expanding their capabilities.
AKUOS
Founded:
2017-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.akuos.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
883.45 K USD
Technology used in webpage:
Euro Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator GoDaddy Premium DNS
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Investors List
Verge HealthTech Fund
Verge HealthTech Fund investment in Seed Round - AKUOS
0711 Venture
0711 Venture investment in Pre Seed Round - AKUOS
LINvestment
LINvestment investment in Pre Seed Round - AKUOS
More informations about "AKUOS" on Search Engine
AKUOS - Crunchbase Company Profile & Funding
Details. Industries. Artificial Intelligence (AI) Headquarters Regions Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia. Founded Date 2017. …See details»
AKUOS - augmenting human capabilities
AKUOS creates products that help augment human capabilities and enable people to break through the physical limitations that come with conditions like hearing loss. Through …See details»
AKUOS Company Profile: Valuation, Funding
Dec 21, 2016 Who is the CEO of AKUOS? Stuart Kerr is the CEO of AKUOS. Where is AKUOS headquartered? AKUOS is headquartered in Singapore, Singapore. What industry is AKUOS in? AKUOS’s primary …See details»
AKUOS | LinkedIn
About us. Improving Lives Through Human Augmentation. site. http://akuos.com. Industry. Medical Equipment Manufacturing. Company size. 2-10 employees. Type. …See details»
Verge HealthTech Fund
Verge HealthTech Fund. Improving lives through human augmentation technology that help people boost their lives. AKUOS is developing world’s most advanced and affordable …See details»
Hardware is harder under COVID and other startup lessons from …
Jun 6, 2020 I started AKUOS having learned a lot from Pirate3D and Dyson, but this isn’t even close to the experience I’m gaining first hand. If I could go back in time (yes, that’s …See details»
AKUOS - Funding, Financials, Valuation & Investors - Crunchbase
Funding. AKUOS has raised a total of. $883.5K. in funding over 3 rounds. Their latest funding was raised on Mar 1, 2020 from a Seed round. AKUOS is funded by 3 investors. …See details»
Akouos, Inc. (AKUS) Upgraded to Strong Buy: Here's Why
Oct 10, 2022 Akouos, Inc. (AKUS) Upgraded to Strong Buy: Here's Why. October 10, 2022 — 12:00 pm EDT. Written by Zacks Equity Research for Zacks -> Akouos, Inc. (AKUS) …See details»
Aquí | Work - AKUOS
Improving lives through human augmentation. AKUOS is a changemaker in the realm of technology that seeks to destigmatise medical treatments to improve the quality of life for …See details»
AKUOS - Contacts, Employees, Board Members, Advisors
Enabling humanity through the elimination of medical stigmaSee details»
Aurello - BAHA Alternative - Bone Conduction Hearing Aid - No …
ABOUT AKUOS designs and manufactures world-class non-invasive Bone Conduction Hearing Aid devices. AKUOS PTE. LTD., 1 Kallang Junction, #06-00, Singapore, 339263See details»
Akouos, Inc. (AKUS) Upgraded to Strong Buy: Here's Why
Oct 10, 2022 Zacks Equity Research. Mon, Oct 10, 2022, 12:00 PM 4 min read. Akouos, Inc. (AKUS) could be a solid choice for investors given its recent upgrade to a Zacks …See details»
Lilly Completes Acquisition of Akouos Expanding Efforts to Help …
Eli Lilly and Company. Dec 01, 2022, 08:41 ET. Share this article. INDIANAPOLIS, Dec. 1, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the …See details»
Akouos – Our Mission: Healthy Hearing Available to All
Our Mission. Healthy hearing available to all. We are a precision genetic medicine company focused on developing gene therapies with the potential to restore, improve, and …See details»
Lilly Completes Acquisition of Akouos Expanding Efforts to Help …
Dec 1, 2022 News Release. Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases. December 1, 2022. Download PDF. …See details»
Eli Lilly Acquires Akouos in Approximately $487 Million Transaction
Dec 2, 2022 Chronic Disease Management. Gene Therapy. Mergers and Acquisitions. Molecular Genetics. Pharmaceutical Companies. On December 1, 2022, Eli Lilly …See details»
Akouos to Present Data from Inner Ear Gene Therapy Platform at …
May 11, 2020 Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity …See details»
Akouos - Crunchbase Company Profile & Funding
Akouos is a biotechnology company focusing on restoring and preserving hearing. Acquired by. Eli Lilly. Boston, Massachusetts, United States. 101-250. Series B. Public. …See details»
Lilly to Acquire Akouos to Discover and Develop Treatments for …
Oct 18, 2022 INDIANAPOLIS and BOSTON, Oct. 18, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced a …See details»
AKOS Foundation Canada
AKOS Foundation Canada is a registered charity supporting the activities of Agape Frontiers, a registered non-governmental organization (NGO) in Tanzania, dedicated to …See details»